Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2026-02-22 @ 7:02 AM
Study NCT ID:
NCT05209620
Status:
RECRUITING
Last Update Posted:
2025-04-23
First Post:
2021-12-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System Lymphoma
Sponsor:
Organization: